Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:ATCCode |
A16AB19
|
| gptkbp:FDAApproved |
2017
|
| gptkbp:form |
solution for infusion
|
| gptkbp:genericName |
gptkb:vestronidase_alfa
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mepsevii
|
| gptkbp:indication |
gptkb:Sly_syndrome
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Ultragenyx_Pharmaceutical
|
| gptkbp:mechanismOfAction |
recombinant human beta-glucuronidase
|
| gptkbp:orphanDrug |
yes
|
| gptkbp:pregnancyCategory |
unknown
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:usedFor |
gptkb:mucopolysaccharidosis_VII
|
| gptkbp:bfsParent |
gptkb:Ultragenyx_Pharmaceutical
gptkb:Ultragenyx |
| gptkbp:bfsLayer |
7
|